NASDAQ:ELOX

Eloxx Pharmaceuticals Stock Forecast

etoro logo Buy ELOX
*Your capital is at risk
$17.43
+4.13 (+31.05%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of ELOX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ELOX to Watchlist?
Some Reasons Why To Add ELOX:
  • Lower volatility than the market (beta -24.60)
  • +1,584,445.5% price growth over the last year
  • Strong return on equity of 72.0%
PDF

Big movements in Eloxx Pharmaceuticals Inc. stock price on Friday moving 30.53% between high and low
(Updated on Jul 31, 2026)

Buy or Hold candidate since Jul 30, 2026 Gain 31.05%

The Eloxx Pharmaceuticals Inc. stock price gained 31.05% on the last trading day (Friday, 31st Jul 2026), rising from $13.30 to $17.43. During the last trading day the stock fluctuated 30.53% from a day low at $13.79 to a day high of $18.00. The price has risen in 6 of the last 10 days and is up by 45.25% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 34 thousand more shares were traded than the day before. In total, 52 thousand shares were bought and sold for approximately $912.83 thousand.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $17.77 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 397.31% during the next 3 months and, with a 90% probability hold a price between $50.46 and $88.39 at the end of this 3-month period.

ELOX Signals & Forecast

The Eloxx Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.12 and $12.56. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 01, 2026, and so far it has risen 4,610.81%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Eloxx Pharmaceuticals Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Eloxx Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $14.00 and $13.88. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Eloxx Pharmaceuticals Inc. finds support just below today's level at $14.00. If this is broken, then the next support from accumulated volume will be at $13.88 and $13.52.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.21 between high and low, or 30.53%. For the last week, the stock has had daily average volatility of 16.35%.

The Eloxx Pharmaceuticals Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $16.83 (-3.42%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 79 and this increases the risk substantially. There is a buy signal from a pivot bottom found 42 days ago.)

Trading Expectations (ELOX) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Eloxx Pharmaceuticals Inc. to open at $16.41, and during the day (based on 14 day Average True Range), to move between $16.39 and $18.47, which gives a possible trading interval of +/-$2.07 (+/-12.64%) up or down from last closing price. If Eloxx Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 12.64% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $14.00, some $3.43 (19.68%) from the current price of $17.43, our system finds the risk reward attractive.

Is Eloxx Pharmaceuticals Inc. stock A Buy?

Eloxx Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $16.41 ( 5.87%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ELOX Performance

Trading levels for ELOX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 20.62 18.28%
R2 19.01 9.06%
R1 18.01 3.36%
Price 17.43
S1 14.80 -15.10%
S2 13.80 -20.80%
S3 12.20 -30.02%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 17.43
S1 14.00 -19.68%
S2 13.88 -20.37%
S3 13.52 -22.43%

FAQ

What is the symbol for Eloxx Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Eloxx Pharmaceuticals Inc. is ELOX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Eloxx Pharmaceuticals Inc. Stock?
Eloxx Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Eloxx Pharmaceuticals Inc. Stock?
Eloxx Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eloxx Pharmaceuticals Inc. Stock.

What's the current price of Eloxx Pharmaceuticals Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Eloxx Pharmaceuticals Inc. (ELOX) share was $17.43.

What is the 52-week high and low for Eloxx Pharmaceuticals Inc. Stock?
The 52-week high for Eloxx Pharmaceuticals Inc. Stock is $18.00 and the 52-week low is $0.0001.

What is the market capitalization of Eloxx Pharmaceuticals Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Eloxx Pharmaceuticals Inc. is 131.997M.

When is the next earnings date for Eloxx Pharmaceuticals Inc.?
The upcoming earnings date for Eloxx Pharmaceuticals Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT ELOXX PHARMACEUTICALS INC.
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for t...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
3.01% Jul 27
UNFI
$49.05
1.39% Jul 27
BIIB
$202.19
2.84% Jul 24
S
SW
$43.71
8.72% Jul 23
I
INTR
$5.62
0.356% Jul 20

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE